• Featured Product
  • KD/KO Validated

FRS2 Polyklonaler Antikörper

FRS2 Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 11503-1-PBS

Synonyme

FGFR substrate 2, FGFR-signaling adaptor SNT, FRS2A, FRS2alpha, SNT



Geprüfte Anwendungen

Produktinformation

11503-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA FRS2 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen FRS2 fusion protein Ag2052
Vollständiger Name fibroblast growth factor receptor substrate 2
Berechnetes Molekulargewicht 60 kDa
Beobachtetes Molekulargewicht 68 kDa
GenBank-ZugangsnummerBC021562
Gene symbol FRS2
Gene ID (NCBI) 10818
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Fibroblast growth factor (FGF) receptor substrate 2 (FRS2) has an alternative name as SNT-1, it is an adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. FGF receptor substrates (FRS2 and FRS3) are key adaptor proteins that mediate FGF-FGFR signalling in benign as well as malignant tissue. FRS2 is a 508 amino-acid protein,which is phosphorylated on tyrosine residues. The molecular weight of non-phosphorylated FRS2 is 57-68 kDa, but phosphorylated FRS2 is 80-90 kDa. Phosphorylation of FRS2 is associated with activation of a number of MAP kinases. Allele-specific regulation of FGFR2 mRNA expression with a mildly increased breast cancer risk has been reported.